Impax Laboratories (IPXL +5.4%) catches a bid after Canaccord Genuity upgrades the firm to Buy...

|About: Impax Laboratories, Inc. (IPXL)|By:, SA News Editor

Impax Laboratories (IPXL +5.4%) catches a bid after Canaccord Genuity upgrades the firm to Buy from Hold with a lofty price target of $28. Shares hit a 6-month high on the strength of the buying flurry.